At a glance
- Originator Taiho Pharmaceutical
- Class Antibacterials; Quinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 15 Jun 2001 Discontinued-Preclinical for Bacterial infections in Japan (Unknown route)